Ocuphire Pharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ocuphire Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Ocuphire Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.38M.
  • Ocuphire Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $8.98M, a 137% increase from 2022.
  • Ocuphire Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.79M, a 86.3% decline from 2021.
  • Ocuphire Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $27.6M, a 30.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.98M +$5.19M +137% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $3.79M -$23.8M -86.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $27.6M +$6.49M +30.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $21.1M +$16.4M +349% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $4.7M -$2.07M -30.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $6.77M -$15.3M -69.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-21
2017 $22.1M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2013 $12.3M +$4.29M +53.2% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-21
2012 $8.05M -$5.54M -40.8% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $13.6M +$909K +7.16% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-22
2010 $12.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.